Concord Medical Services Holdings Limited
CCM · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $384 | $537 | $472 | $486 |
| % Growth | -28.6% | 13.8% | -2.8% | – |
| Cost of Goods Sold | $463 | $614 | $624 | $543 |
| Gross Profit | -$79 | -$77 | -$152 | -$57 |
| % Margin | -20.6% | -14.3% | -32.3% | -11.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $404 | $330 | $311 | $348 |
| SG&A Expenses | $453 | $386 | $373 | $401 |
| Sales & Mktg Exp. | $49 | $56 | $61 | $54 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $453 | $386 | $373 | $401 |
| Operating Income | -$532 | -$463 | -$525 | -$458 |
| % Margin | -138.6% | -86.2% | -111.2% | -94.4% |
| Other Income/Exp. Net | -$137 | -$93 | -$315 | -$71 |
| Pre-Tax Income | -$670 | -$556 | -$840 | -$529 |
| Tax Expense | -$18 | -$25 | -$71 | -$7 |
| Net Income | -$308 | -$298 | -$490 | -$271 |
| % Margin | -80.3% | -55.4% | -103.7% | -55.9% |
| EPS | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| % Growth | -3.6% | 39.2% | 40.3% | – |
| EPS Diluted | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $11 | $10 | $6 |
| Interest Expense | $193 | $166 | $120 | $74 |
| Depreciation & Amortization | $131 | $119 | $123 | $94 |
| EBITDA | -$346 | -$344 | -$402 | -$364 |
| % Margin | -90% | -64% | -85.1% | -74.9% |